Common diabetes drug metformin may slow aging, researchers say
Researchers report metformin, a widely used diabetes medication, could help slow certain biological signs of aging, according to recent studies.
A study suggests the widely prescribed diabetes medication metformin may possess anti-aging properties, according to recent research. Metformin, commonly used to treat type 2 diabetes, could potentially slow specific biological markers of aging. The mechanisms through which metformin exerts its effects may be more intricate than previously assumed, leading scientists to explore its implications for aging and longevity.
One notable effect of metformin is its ability to activate an enzyme vital for regulating cellular energy. Additionally, metformin may hinder a pathway responsible for autophagy, the cellular process of eliminating and reusing damaged or unnecessary components. These actions could contribute to reduced oxidative stress, enhanced insulin sensitivity, and maintained cell function—factors linked to improved health during the aging process.
Early results indicate that metformin might impact certain epigenetic modifications tied to aging and modify gut bacteria composition, potentially leading to decreased inflammation and better gut and metabolic health.
Written by urgent.news from Ajel English's reporting — not their text. Machine-written — may contain errors; check the original before relying on it.
